Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Financial Respite For Sangamo As Roche Signs Neurodegeneration Disease Pact

Aug 07 2024

• By Alexandra Shimmings

Tau Alzheimer's disease — TAU

Related Content

Pfizer’s Hemophilia A Gene Therapy Superior To Prophylaxis In Phase III

Jul 24 2024

Related Companies

Sangamo Therapeutics, Inc.

Roche Holding AG

Genentech, Inc.

Pfizer Inc.

UCB S.A.

Additional Topics

Companies Deals Research & Development Commercial StartUps and SMEs Neurology BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.